Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2022 (1)
  • 2021 (1)
  • 2020 (2)
  • 2019 (4)
  • 2018 (10)

Subject

  • Drug Trafficking (10)
  • Prescription Drugs (5)
  • Money Laundering (4)
  • Take Back Day (4)
  • Arrests/Convictions - Major (3)
  • Gangs (2)
  • Overdose (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Major Law Enforcement Operation (1)
  • OCDETF/Task Force (1)
  • Outreach/Drug Prevention (1)
  • Pharmaceuticals/Pharmacists/Physicians (1)
  • Press Conferences (1)
  • Red Ribbon (1)
  • Congressional Affairs (10)
  • Scam Calls (0)

Drug Name

  • Synthetic Opioids (3)
  • Fentanyl (1)

Field Division

  • Sede (9)
  • Louisville (1)
Clear All Results
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

Noviembre 02, 2018
WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
Noviembre 02, 2018
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

Agosto 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
Agosto 31, 2018
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

Agosto 28, 2018
CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
Agosto 28, 2018
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

Agosto 16, 2018
WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
Agosto 16, 2018
PRESS RELEASE

Department of Justice announces regulatory steps to address opioid epidemic

Julio 11, 2018
WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...
Julio 11, 2018
PRESS RELEASE

Senior Sinaloa Cartel leader extradited to the United States

Julio 06, 2018
WASHINGTON –Mexican authorities today extradited Sinaloa Cartel leader Damaso Lopez Nuñez, also known as “El Licenciado,” to the United States to face drug trafficking charges filed in the Eastern District of Virginia. Acting Assistant Attorney General John P. Cronan of the Justice Department’s Criminal Division; U.S. Attorney G. Zachary Terwilliger...
Julio 06, 2018
PRESS RELEASE

Attorney General Jeff Sessions Announces Uttam Dhillon as New Acting Administrator Of Drug Enforcement Administration

Julio 02, 2018
WASHINGTON – Today, Attorney General Jeff Sessions announced the appointment of Uttam Dhillon as Acting Administrator of the Drug Enforcement Administration. Dhillon will replace Robert Patterson, who has retired after 30 years of service. "With one American dying of a drug overdose every nine minutes, there can be no doubt...
Julio 02, 2018
PRESS RELEASE

National Health Care Fraud Takedown Results in Charges against 601 Individuals Responsible for over $2 Billion in Fraud Losses

Junio 28, 2018
WASHINGTON – Attorney General Jeff Sessions and Department of Health and Human Services (HHS) Secretary Alex M. Azar III, announced today the largest ever health care fraud enforcement action involving 601 charged defendants across 58 federal districts, including 165 doctors, nurses and other licensed medical professionals, for their alleged participation...
Junio 28, 2018
PRESS RELEASE

Fugitive Wanted For The Kidnapping And Murder Of A Federal Agent Is Added To The FBI’s “Ten Most Wanted Fugitives” List

Abril 12, 2018
WASHINGTON - Federal Bureau of Investigation Deputy Director David L. Bowdich, Drug Enforcement Administration Acting Administrator Robert W. Patterson, U.S. Department of State Deputy Assistant Secretary James Walsh, and U.S. Marshals Service Acting Associate Director Derrick Driscoll today announced the addition of fugitive Rafael Caro-Quintero to the FBI’s list of...
Abril 12, 2018
PRESS RELEASE

DEA announces the establishment of a new Division Office in Omaha

Marzo 07, 2018
(OMAHA, Neb.) – The Drug Enforcement Administration will establish the Omaha Field Division – its 23rd division office in the United States – on July 8, 2018. The division will include Nebraska, Iowa, Minnesota, North Dakota and South Dakota. “This action converts the existing Omaha District Office into a division...
Marzo 07, 2018
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster